Three-year results following regenerative periodontal surgery of advanced intrabony defects with enamel matrix derivative alone or combined with a synthetic bone graft
- PMID: 26174080
- DOI: 10.1007/s00784-015-1522-4
Three-year results following regenerative periodontal surgery of advanced intrabony defects with enamel matrix derivative alone or combined with a synthetic bone graft
Abstract
Objectives: This study aims to compare the clinical outcomes of a combination of enamel matrix derivatives (EMD) and a synthetic bone graft (biphasic calcium phosphate) with EMD alone in wide and deep one- and two-wall intrabony defects 36 months after treatment.
Material and methods: Thirty patients with chronic periodontitis and one wide (≥ 2 mm) and deep (≥ 4 mm) intrabony defect had been recruited in three centres in Germany. During surgery, defects were randomly assigned to EMD/synthetic bone graft (SBG) (test) or EMD (control). Assessments at baseline, after 6, 12 and 36 months, included bone sounding, relative clinical attachment levels, probing pocket depths and recessions.
Results: After 36 months, defects in both groups were significantly improved (p < 0.001) with regard to defect fill, attachment gain and probing pocket reduction. In the EMD/SBG group, a mean defect fill of 2.6 mm (±1.7) was measured, and in the EMD group, the defect fill was 2.3 mm (±1.5). A mean gain in clinical attachment of 4.1 mm (±3.6) and 3.8 mm (±2.2) was observed in the test and in the control group, respectively. There were no statistically significant differences in any of the investigated parameters between the two treatment modalities.
Conclusions: The clinical improvements of advanced intrabony defects obtained with both regenerative modalities could be maintained over a period of 3 years. The combination of EMD with SBG did not show any advantage compared to the use of EMD alone.
Keywords: Bone replacement graft; Enamel matrix derivative; Intrabony defects; Randomized clinical trial; Regenerative periodontal therapy.
Similar articles
-
A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months.J Clin Periodontol. 2011 Jul;38(7):652-60. doi: 10.1111/j.1600-051X.2011.01726.x. Epub 2011 May 12. J Clin Periodontol. 2011. PMID: 21564156 Clinical Trial.
-
Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate.Clin Oral Investig. 2012 Aug;16(4):1191-7. doi: 10.1007/s00784-011-0611-2. Epub 2011 Sep 1. Clin Oral Investig. 2012. PMID: 21881869 Clinical Trial.
-
Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.J Clin Periodontol. 2010 Jun;37(6):544-50. doi: 10.1111/j.1600-051X.2010.01567.x. J Clin Periodontol. 2010. PMID: 20507378 Clinical Trial.
-
Periodontal regeneration - intrabony defects: a consensus report from the AAP Regeneration Workshop.J Periodontol. 2015 Feb;86(2 Suppl):S105-7. doi: 10.1902/jop.2015.140378. Epub 2014 Oct 15. J Periodontol. 2015. PMID: 25315019
-
The use of enamel matrix derivative alone versus in combination with bone grafts to treat patients with periodontal intrabony defects: a meta-analysis.J Am Dent Assoc. 2012 Sep;143(9):e46-56. doi: 10.14219/jada.archive.2012.0327. J Am Dent Assoc. 2012. PMID: 22942155 Review.
Cited by
-
Unlocking the Future of Periodontal Regeneration: An Interdisciplinary Approach to Tissue Engineering and Advanced Therapeutics.Biomedicines. 2024 May 14;12(5):1090. doi: 10.3390/biomedicines12051090. Biomedicines. 2024. PMID: 38791052 Free PMC article. Review.
-
Identification of Genes Differentially Expressed in Simvastatin-Induced Alveolar Bone Formation.JBMR Plus. 2019 Jan 2;3(5):e10122. doi: 10.1002/jbm4.10122. eCollection 2019 May. JBMR Plus. 2019. PMID: 31131344 Free PMC article.
-
Bony Defect Regeneration in Periodontitis: A Systematic Review of the Literature Regarding the Use of Enamel Matrix Derivative Proteins.Dent J (Basel). 2025 Feb 20;13(3):92. doi: 10.3390/dj13030092. Dent J (Basel). 2025. PMID: 40136720 Free PMC article. Review.
-
Enamel matrix derivative monotherapy versus combination therapy with bone grafts for periodontal intrabony defects: An updated review.Jpn Dent Sci Rev. 2024 Dec;60:239-249. doi: 10.1016/j.jdsr.2024.08.001. Epub 2024 Oct 23. Jpn Dent Sci Rev. 2024. PMID: 39507278 Free PMC article. Review.
-
A 5-year prospective study on regenerative periodontal therapy of infrabony defects using minimally invasive surgery and a collagen-enriched bovine-derived xenograft.Clin Oral Investig. 2018 Apr;22(3):1235-1242. doi: 10.1007/s00784-017-2208-x. Epub 2017 Sep 30. Clin Oral Investig. 2018. PMID: 28965250
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical